INCY · Company research
Incyte Genomics Inc (INCY): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 113.44 | $25,989,521,120 | 22007146120.00 | 44.4199288256227758 | — | 1.1768396727827334 | 15.5250392135428147 | 4.0964331562172597 | 52.4776852048161627 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.